RxCelerate
Andrew Carr is a seasoned professional in the field of chemistry operations with extensive experience in pharmaceutical development. Currently serving as the Director of Chemistry Operations at RXCELERATE LIMITED since January 2024, Andrew previously held key roles at Charles River Laboratories, including Senior Group Leader and Pharmaceutics Team Leader, where expertise in solid-state, physicochemical, and formulation science facilitated the selection of robust pre-clinical drug candidates. Prior experience includes Senior Scientist and Project Leader at Pharmorphix - Johnson Matthey, as well as positions at Lectus Therapeutics, Sareum Ltd, Medivir AB, and Oxford GlycoSciences. Andrew holds an MChem degree in Chemistry from the University of York, awarded in 2001.
This person is not in any teams
RxCelerate
1 followers
RxCelerate Limited is a leading outsourced drug development company based in Cambridge (U.K) delivering complete preclinical programmes to our clients. We offer a comprehensive suite of services under one roof, including in silico modelling, medicinal chemistry, in vitro and preclinical capabilities, and project management. We pride ourselves on our ability to deliver innovative cutting-edge experimental solutions that save our clients time and money. Our flexible approach, commitment to quality, and ability to deliver results quickly make us the perfect partner for unlocking the true potential of your drug development journey. We are not just a company; we are a people-first organisation. We invest in and value our employees and have created an environment that encourages collaboration, innovation and personal growth. We foster a culture of inclusivity, where every team member’s voice is heard, and their ideas are valued. Connect with us to be part of our exciting journey!